Literature DB >> 19643062

Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 - an internet-based cross-sectional survey.

A Kitching1, A Roche, S Balasegaram, R Heathcock, H Maguire.   

Abstract

This report describes the results of a cross-sectional anonymised online survey on adherence to, and side effects from oseltamivir when offered for prophylaxis, among pupils from one primary and two secondary schools with confirmed cases of influenza A(H1N1)v in London in April-May 2009. Of 103 respondents (response rate 40%), 95 were estimated to have been offered oseltamivir for prophylaxis, of whom 85 (89%) actually took any. Less than half (48%) of primary schoolchildren completed a full course, compared to three-quarters (76%) of secondary schoolchildren. More than half (53%) of all schoolchildren taking prophylactic oseltamivir reported one or more side effects. Gastrointestinal symptoms were reported by 40% of children and 18% reported a mild neuropsychiatric side effect. The results confirmed anecdotal evidence of poor adherence, provided timely information with which to assist decision-making, and formed part of the body of growing evidence that contributed to policy changes to restrict widespread use of prophylaxis for school contacts of confirmed cases of influenza A(H1N1)v.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643062     DOI: 10.2807/ese.14.30.19287-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  27 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.

Authors:  Esther Lera; Núria T Wörner; Mónica Sancosmed; Anna Fàbregas; Alejandro Casquero; Susana Melendo; Mar Miserachs; Teresa Tórtola; Astrid Borrego; Magda Campins; Fernando Moraga; Concepció Figueras; Rocío Cebrián
Journal:  Eur J Pediatr       Date:  2011-01-28       Impact factor: 3.183

3.  Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia.

Authors:  Jodie McVernon; Kate Mason; Sylvia Petrony; Paula Nathan; Anthony D LaMontagne; Rebecca Bentley; James Fielding; David M Studdert; Anne Kavanagh
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

4.  The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary.

Authors:  Upton D Allen
Journal:  Paediatr Child Health       Date:  2013-03       Impact factor: 2.253

5.  The national pandemic flu service, oseltamivir, and a case of pancreatitis.

Authors:  Richard Newton; Dominic King; Henry Lee; Mike Anderson; John Lynn
Journal:  BMJ Case Rep       Date:  2010-04-09

6.  The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013.

Authors:  Fred Y Aoki; Upton D Allen; H Grant Stiver; Gerald A Evans
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 7.  Prevention of influenza in healthy children.

Authors:  Bruce Y Lee; Mirat Shah
Journal:  Expert Rev Anti Infect Ther       Date:  2012-10       Impact factor: 5.091

8.  Antiviral drugs for treatment of patients infected with pandemic (H1N1) 2009 virus.

Authors:  David M Hartley; Noele P Nelson; Eli N Perencevich
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

9.  Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009--a waste water epidemiology study.

Authors:  Andrew C Singer; Josef D Järhult; Roman Grabic; Ghazanfar A Khan; Ganna Fedorova; Jerker Fick; Richard H Lindberg; Michael J Bowes; Björn Olsen; Hanna Söderström
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir.

Authors:  Miki Hiasa; Yumiko Isoda; Yasushi Kishimoto; Kenta Saitoh; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki; Dai Hatakeyama; Yutaka Kirino; Takashi Kuzuhara
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.